Health and Human Performance, Middle Tennessee State University, 1301 E. Main Street Box 96, Murfreesboro, TN, 37132, USA.
Center for Health and Human Services, Middle Tennessee State University, 1114 East Lytle Street Box 99, Murfreesboro, TN, 37132, USA.
Harm Reduct J. 2024 Nov 9;21(1):195. doi: 10.1186/s12954-024-01114-7.
The U.S. opioid crisis, resulting in nearly 500,000 deaths from 1999 to 2019, has been exacerbated by persistent stigma, which hinders treatment and recovery efforts. This stigma, whether structural, social, or self-imposed, challenges overdose prevention and recovery. Our study aimed to assess and compare levels of stigma towards opioid users among rural law enforcement officers (LEOs) and community members in Tennessee, highlighting rural community-level attitudes.
Methods involved surveying two groups: LEOs (N=48) and community members (N=393). Utilizing a Likert Scale based on prior research, the survey probed attitudes toward drug use across four stigma domains: dangerousness, blame, social distancing, and fatalism. Analysis employed standardized scoring and ANOVA for evaluating stigma differences by participant characteristics.
LEOs (75%) and community members (51.7%) predominantly identify drug users as white, with varied perceptions regarding socioeconomic status and employment. Despite similar perceptions, normalized stigma scores revealed statistical differences between groups across stigma domains. ANOVA found no significant impact of participant type or gender on stigma levels, though race/ethnicity and its interaction with gender suggested potential influences on overall stigma score.
Both LEOs and community members in rural Tennessee hold measurable stigma against opioid users, spanning dangerousness, blame, social distancing, and fatalism domains. These insights highlight the need for further research into both professional and public attitudes toward individuals with opioid or other substance use disorders within shared communities. This research should aim to develop specific stigma-reducing interventions that target both providers and community members.
从 1999 年到 2019 年,美国的阿片类药物危机导致近 50 万人死亡,而持续存在的污名化现象加剧了这一危机,这阻碍了治疗和康复工作。这种污名化,无论是结构性的、社会性的还是自我强加的,都对过量预防和康复构成了挑战。我们的研究旨在评估和比较田纳西州农村执法人员(LEO)和社区成员对阿片类药物使用者的污名程度,重点关注农村社区层面的态度。
该方法涉及对两组人员进行调查:执法人员(N=48)和社区成员(N=393)。利用基于先前研究的李克特量表,该调查探究了对四个污名领域的药物使用态度:危险性、责备、社会疏远和宿命论。分析采用标准化评分和方差分析来评估参与者特征对污名差异的影响。
执法人员(75%)和社区成员(51.7%)主要将吸毒者视为白人,对其社会经济地位和就业情况有不同的看法。尽管看法相似,但标准化污名评分显示出两组在污名领域存在统计学差异。方差分析发现参与者类型或性别对污名水平没有显著影响,但种族/民族及其与性别的相互作用表明对总体污名评分可能存在影响。
田纳西州农村地区的执法人员和社区成员都对阿片类药物使用者存在可衡量的污名化,涵盖了危险性、责备、社会疏远和宿命论领域。这些发现强调了需要进一步研究专业人员和公众对共同社区中阿片类药物或其他物质使用障碍患者的态度。这项研究应旨在制定具体的减少污名化干预措施,针对提供者和社区成员。